BCRXNasdaq United States
Market cap
$2.397 B
$9.38 +0.86%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
$263.9M
#892 by earnings
Shares outstanding
255,535,105
Latest filing cover page
P/E ratio
9.1
Cap ÷ net income
Where these numbers come from
Share counts and financials for Biocryst Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.